Nanomaterials for biomedical applications
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- COMISION NACIONAL DE ENERGIA ATOMICA
Argentina's national nuclear research centre contributing nanomagnetism, computational modelling, and materials science expertise to European research networks.
“Involved in MAGNAMED (cancer diagnostics via magnetic vortex states), NESTOR (nanozymes for oxidative stress control), and HYMADE (hybrid drug delivery systems).”
PrimaryAR9 projects - UNIVERSITE D'ARTOIS
French university with research strengths in nanomaterials for drug delivery, neuroscience, and an emerging focus on trustworthy AI.
“NANOSTEM (neural stem cell drug delivery, largest grant at EUR 525K) and in3 (nanomaterial safety assessment) both center on nanomaterial research.”
PrimaryFR6 projects - DELSITECH OY
Finnish developer of pH-responsive mesoporous matrices for localized therapeutic ion and drug delivery
“MOZART falls under the P2-NANO pillar, confirming their material systems operate at nanoscale dimensions for biomedical use cases.”
FI2 projects